Drug Search Results
More Filters [+]

Oxytetracycline

Alternative Names: oxytetracycline, terramycin, oxy-kesso-tetra, terra-cortril
Latest Update: 2024-11-29
Latest Update Note: News Article

Product Description

Oxytetracycline is a bacteriostatic antibiotic. Newly discovered, additional mechanisms of action include antioxidant, antiinflammatory and immynosupresive activity of oxytetracycline and other tetracyclines.  (Sourced from: https://pubmed.ncbi.nlm.nih.gov/17427500/)

Mechanisms of Action: Protein Synthesis Inhibitor,30S Ribosomal Subunit Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Intramuscular,Intravenous,Oral

FDA Designation: None *

Approval Status: Approved

Approved Countries: Algeria | Austria | Bangladesh | Belgium | Brazil | Bulgaria | China | Colombia | Croatia | Denmark | Dominican Republic | Ecuador | Egypt | France | Germany | Greece | Hong Kong | Hungary | India | Indonesia | Ireland | Italy | Jordan | Korea | Malaysia | Mexico | Morocco | New Zealand | Norway | Pakistan | Peru | Philippines | Poland | Portugal | Russia | Slovenia | South Africa | Spain | Sweden | Taiwan | Tunisia | Turkey | Ukraine | United Kingdom | Venezuela | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: Julio Ramirez
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Oxytetracycline

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 1: Osteomyelitis

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

PRESTO:Osteo

P1

Terminated

Osteomyelitis

2018-11-07

Recent News Events